Literature DB >> 24859842

Success rate of cold coagulation for the treatment of cervical intraepithelial neoplasia: a retrospective analysis of a series of cases.

William Parry-Smith1, Martyn Underwood, Sabrina De Bellis-Ayres, Laura Bangs, Charles W E Redman, Jane Panikkar.   

Abstract

OBJECTIVE: To establish the cure rate at 1 year of patients who have undergone cold coagulation for the treatment of cervical intraepithelial neoplasia (CIN).
DESIGN: Retrospective review of data for all patients at Shrewsbury and Telford NHS Trust who had undergone cold coagulation as part of their treatment for CIN between 2001 and 2011. Follow-up data up to December 2012 were analyzed.
SETTING: Colposcopy Department, Shrewsbury and Telford NHS Trust, United Kingdom. POPULATION: Women undergoing cold coagulation for the treatment of CIN between 2001 and 2011, with cytologic follow-up until December 2012.
METHODS: Patients were identified using a local colposcopy database. Data were obtained via the local histopathology reporting systems. Statistical analyses were performed using Stata/IC 10.1 software. MAIN OUTCOME MEASURES: Posttreatment cytology and whether subsequent treatment was required, with histology results.
RESULTS: Data on 557 patients were collected and analyzed. Pre-cold coagulation treatment histologic findings were CIN 1 in 156 patients (28.01%), CIN 2 in 260 patients (46.68%), and CIN 3 in 141 patients (25.31%). The median length of time between cold coagulation treatment and first follow-up smear, used to calculate cure rates at around 1 year, was 406 days (interquartile range 123 days, range 169-3,116 days). The cure rate after cold coagulation was 95.7% at around 1 year.
CONCLUSIONS: Cold coagulation has a cure rate comparable to that of excisional treatments such as large loop excision of the transformation zone and should be considered more widely in patients undergoing primary treatment for CIN, where there is no suspicion of invasive disease on history, examination and cytologic results.

Entities:  

Mesh:

Year:  2015        PMID: 24859842     DOI: 10.1097/LGT.0000000000000031

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  9 in total

1.  Does CIN2 Have the Same Aggressive Potential As CIN3? A Secondary Analysis of High-Grade Cytology Recurrence in Women Treated with Cold-Coagulation Cervical Treatment.

Authors:  D Papoutsis; M Underwood; W Parry-Smith; J Panikkar
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-03       Impact factor: 2.915

Review 2.  Thermal Ablation Treatment for Cervical Precancer (Cervical Intraepithelial Neoplasia Grade 2 or Higher [CIN2+]).

Authors:  Montserrat Soler; Rachel Masch; Rakiya Saidu; Miriam Cremer
Journal:  Methods Mol Biol       Date:  2022

3.  Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.

Authors:  Lameck Chinula; Hillary M Topazian; Clement Mapanje; Amanda Varela; John Chapola; Laura Limarzi; Christopher Stanley; Mina Hosseinipour; Satish Gopal; Jennifer H Tang
Journal:  Int J Cancer       Date:  2021-03-23       Impact factor: 7.316

4.  Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.

Authors:  Manuela Viviano; Bruno Kenfack; Rosa Catarino; Eveline Tincho; Liliane Temogne; Anne-Caroline Benski; Pierre-Marie Tebeu; Ulrike Meyer-Hamme; Pierre Vassilakos; Patrick Petignat
Journal:  BMC Womens Health       Date:  2017-01-07       Impact factor: 2.809

5.  Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.

Authors:  Margot Kunckler; Fanny Schumacher; Bruno Kenfack; Rosa Catarino; Manuela Viviano; Eveline Tincho; Pierre-Marie Tebeu; Liliane Temogne; Pierre Vassilakos; Patrick Petignat
Journal:  Cancer Med       Date:  2017-06-04       Impact factor: 4.452

6.  Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.

Authors:  Heather A Cubie; Christine Campbell
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

7.  Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.

Authors:  Christine Campbell; Savel Kafwafwa; Hilary Brown; Graeme Walker; Belito Madetsa; Miriam Deeny; Beatrice Kabota; David Morton; Reynier Ter Haar; Liz Grant; Heather A Cubie
Journal:  Int J Cancer       Date:  2016-05-04       Impact factor: 7.396

Review 8.  Ablative Therapies for Cervical Intraepithelial Neoplasia in Low-Resource Settings: Findings and Key Questions.

Authors:  Miriam L Cremer; Gabriel Conzuelo-Rodriguez; William Cherniak; Thomas Randall
Journal:  J Glob Oncol       Date:  2018-10

9.  Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN.

Authors:  G M Armstrong; K Ragupathy
Journal:  Arch Gynecol Obstet       Date:  2022-02-02       Impact factor: 2.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.